MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement

On August 30, 2017, Medical Transcription Billing, Corp. (“MTBC” or the “Company”) entered into a Placement Agency Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC to which the Company agreed to issue and sell 15,000 shares of its 11% Series A Cumulative Redeemable Preferred Stock in a public offering to a Registration Statement on Form S-3 (File No. 333-210391) and a related prospectus, including the related prospectus supplement, filed with the Securities and Exchange Commission.

The net proceeds of the offering to the Company were approximately $317,000, after deducting placement agency fees and other estimated offering expenses. The Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.

In connection with the offering referenced above, the legal opinion as to the legality of the series A preferred stock sold is being filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein and into the Registration Statement by reference.

(S)

MEDICAL TRANSCRIPTION BILLING, CORP Exhibit
EX-1.1 2 ex1-1.htm   Execution Version   PLACEMENT AGENCY AGREEMENT   August 30,…
To view the full exhibit click here

MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Recent Trading Information

MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) closed its last trading session up +0.20 at 25.50 with 3,853 shares trading hands.